Overview
SCIENTIFIC SCORE
Moderately Effective
Based on 7 Researches
8.9
USERS' SCORE
Moderately Good
Based on 3 Reviews
7.5
Supplement Facts
Serving Size: 2 Soft Gels
Amount Per Serving
%DV
Calories
10
Total Fat
1 g
1%
Saturated Fat
0 g
0%
Trans Fat
0 g
†
Vitamin D3 (cholecalciferol)
10 mcg (400 IU)
67%
Total Omega-3s♦
830 mg
†
EPA (Eicosapentaenoic Acid)
205 mg
†
DHA (Docosahexaenoic Acid)
480 mg
†
Top Medical Research Studies
9
We sought to understand the impact of severe vitamin D deficiency on benign paroxysmal positional vertigo (BPPV), a common cause of dizziness. Previous studies showed a connection between low vitamin D levels and both the onset and recurrence of BPPV, but none had conclusively demonstrated that addressing this deficiency could lessen the recurrence of symptoms.
To examine this further, we included patients diagnosed with unilateral, idiopathic posterior canal BPPV and severe vitamin D deficiency, indicated by levels of 25-hydroxyvitamin D3 at or below 10 ng/ml. After thorough evaluations including hearing tests and balance assessments, we prescribed vitamin D therapy to our participants.
Over the following months, we monitored the changes in their vitamin D levels and followed up with them for 18 months to observe any recurrence of dizziness. Our findings revealed that patients who showed an improvement in their vitamin D levels experienced a significant reduction in the recurrence of BPPV symptoms.
This suggests that by addressing vitamin D deficiency, we can potentially offer a more effective approach to managing BPPV—lessening those troublesome dizzy spells that can really impact quality of life.
To examine this further, we included patients diagnosed with unilateral, idiopathic posterior canal BPPV and severe vitamin D deficiency, indicated by levels of 25-hydroxyvitamin D3 at or below 10 ng/ml. After thorough evaluations including hearing tests and balance assessments, we prescribed vitamin D therapy to our participants.
Over the following months, we monitored the changes in their vitamin D levels and followed up with them for 18 months to observe any recurrence of dizziness. Our findings revealed that patients who showed an improvement in their vitamin D levels experienced a significant reduction in the recurrence of BPPV symptoms.
This suggests that by addressing vitamin D deficiency, we can potentially offer a more effective approach to managing BPPV—lessening those troublesome dizzy spells that can really impact quality of life.
Read More
9
We conducted a double-blinded randomized controlled trial to explore the effects of Vitamin D3 on the recurrence of BPPV, a condition that causes dizziness in older adults.
Our study involved participants who were initially vitamin D3 deficient. They were divided into two groups: one receiving a treatment of Vitamin D3 and the other a placebo. Over 12 months, participants who received the vitamin showed an impressive 87% reduction in their BPPV recurrence rates compared to those on placebo. Additionally, they experienced a longer time before their first episode of dizziness returned.
However, when we compared the treatment group to those who were already vitamin D replete, we found no significant difference in terms of recurrence rates or dizziness severity scores. This suggests that while Vitamin D3 treatment can reduce episodes of BPPV, its benefits may not extend to all older adults, particularly if they already have adequate vitamin D levels.
Overall, our findings lay the groundwork for further research into Vitamin D3's role in treating BPPV, potentially informing future clinical practice to help reduce risks of falls in older adults.
Our study involved participants who were initially vitamin D3 deficient. They were divided into two groups: one receiving a treatment of Vitamin D3 and the other a placebo. Over 12 months, participants who received the vitamin showed an impressive 87% reduction in their BPPV recurrence rates compared to those on placebo. Additionally, they experienced a longer time before their first episode of dizziness returned.
However, when we compared the treatment group to those who were already vitamin D replete, we found no significant difference in terms of recurrence rates or dizziness severity scores. This suggests that while Vitamin D3 treatment can reduce episodes of BPPV, its benefits may not extend to all older adults, particularly if they already have adequate vitamin D levels.
Overall, our findings lay the groundwork for further research into Vitamin D3's role in treating BPPV, potentially informing future clinical practice to help reduce risks of falls in older adults.
Read More
8
We conducted a study to understand how 1α-hydroxyvitamin D3 affects patients with benign paroxysmal positional vertigo (BPPV), a common cause of dizziness. In this study, we selected 100 BPPV patients from the ENT Department of Anzhen Hospital—50 received daily doses of 0.25 µg 1α-hydroxyvitamin D3 in addition to standard care, while the other 50 only received the usual treatment.
After analyzing the bone mineral density (BMD) and vitamin D levels before and after treatment, we discovered some promising results. The BMD of both male and female patients taking vitamin D3 significantly improved following treatment, which was not the case for the control group. Furthermore, we found that higher levels of vitamin D3 and the presence of osteopenia or osteoporosis played a crucial role in the effectiveness of BPPV treatment.
Our findings indicate that 1α-hydroxyvitamin D3 can effectively alleviate dizziness symptoms related to BPPV, making it a noteworthy addition to standard treatment protocols. This study highlights the importance of vitamin D levels in managing BPPV and suggests further exploration into its benefits for those suffering from dizziness.
After analyzing the bone mineral density (BMD) and vitamin D levels before and after treatment, we discovered some promising results. The BMD of both male and female patients taking vitamin D3 significantly improved following treatment, which was not the case for the control group. Furthermore, we found that higher levels of vitamin D3 and the presence of osteopenia or osteoporosis played a crucial role in the effectiveness of BPPV treatment.
Our findings indicate that 1α-hydroxyvitamin D3 can effectively alleviate dizziness symptoms related to BPPV, making it a noteworthy addition to standard treatment protocols. This study highlights the importance of vitamin D levels in managing BPPV and suggests further exploration into its benefits for those suffering from dizziness.
Read More
Most Useful Reviews
9
Reduces dizziness
3 people found this helpful
I took this from the sixth month of pregnancy while breastfeeding. I observed my baby gained weight well and was healthy, which is different from my previous children. This is my experience, and I believe it helped with dizziness.
Read More
7.5
Eases dizziness
3 people found this helpful
I experienced increased dizziness and palpitations from four months pregnant. I began taking DHA as it’s beneficial for fetal brain development. Initially, there was a strong smell, but keeping it in the fridge helped. My dizziness has decreased, and I will continue taking it.
Read More
0
Helps with dizziness
11 people found this helpful
Good, but I am unsure about the Omega 3. I’ve experienced more severe dizziness with my anaemia during pregnancy. Initially, I didn’t realise how this was affecting me. I do take it now as I believe the fish oil can benefit my baby's intelligence.
Read More
Medical Researches
SCIENTIFIC SCORE
Moderately Effective
Based on 7 Researches
8.9
- All Researches
9.5
We explored how vitamin D3, coupled with antioxidant supplements, can help prevent recurrent cases of benign paroxysmal positional vertigo (BPPV), a common type of dizziness. In this multicentric trial involving 128 patients who experienced frequent episodes of BPPV, we organized participants into three groups based on their vitamin D levels and treatment.
The first group received vitamin D3 along with a combination of alpha-lipoic acid, Carnosine, and Zinc, as well as vitamins from the B group. The second group, with sufficient vitamin D but no supplementation, served as a control. Meanwhile, the third group had sufficient vitamin D and received a different antioxidant mix.
After a six-month follow-up, we observed a significant reduction in dizziness relapses only among those in the first group who had insufficient or deficient vitamin D levels prior to treatment. Unfortunately, the other groups did not show similar improvements. This highlights the importance of addressing vitamin D deficiency, especially for those prone to recurrent dizziness. However, we must be cautious, as the combination of different supplements makes it challenging to isolate the effects solely attributed to vitamin D3.
The first group received vitamin D3 along with a combination of alpha-lipoic acid, Carnosine, and Zinc, as well as vitamins from the B group. The second group, with sufficient vitamin D but no supplementation, served as a control. Meanwhile, the third group had sufficient vitamin D and received a different antioxidant mix.
After a six-month follow-up, we observed a significant reduction in dizziness relapses only among those in the first group who had insufficient or deficient vitamin D levels prior to treatment. Unfortunately, the other groups did not show similar improvements. This highlights the importance of addressing vitamin D deficiency, especially for those prone to recurrent dizziness. However, we must be cautious, as the combination of different supplements makes it challenging to isolate the effects solely attributed to vitamin D3.
Read More
9.5
We explored how normalization of vitamin D levels may impact the recurrence of dizziness caused by benign paroxysmal positional vertigo (BPPV). This case-control study included patients with a history of BPPV who had low serum vitamin D levels. We divided participants into two groups: one received additional vitamin D3, while both groups underwent Epley rehabilitation therapy.
Over the course of two months, the treatment group raised their vitamin D levels significantly, while the control group did not see any change. Following this treatment period, we observed a remarkable difference in the recurrence of BPPV attacks; the group receiving vitamin D3 experienced far fewer episodes compared to the control group.
Our results indicate that boosting vitamin D3 levels significantly reduces the number of recurrent dizziness episodes in patients with BPPV. This suggests that addressing vitamin D deficiency may play a key role in managing dizziness in affected patients.
Over the course of two months, the treatment group raised their vitamin D levels significantly, while the control group did not see any change. Following this treatment period, we observed a remarkable difference in the recurrence of BPPV attacks; the group receiving vitamin D3 experienced far fewer episodes compared to the control group.
Our results indicate that boosting vitamin D3 levels significantly reduces the number of recurrent dizziness episodes in patients with BPPV. This suggests that addressing vitamin D deficiency may play a key role in managing dizziness in affected patients.
Read More
9
We conducted a double-blinded randomized controlled trial to explore the effects of Vitamin D3 on the recurrence of BPPV, a condition that causes dizziness in older adults.
Our study involved participants who were initially vitamin D3 deficient. They were divided into two groups: one receiving a treatment of Vitamin D3 and the other a placebo. Over 12 months, participants who received the vitamin showed an impressive 87% reduction in their BPPV recurrence rates compared to those on placebo. Additionally, they experienced a longer time before their first episode of dizziness returned.
However, when we compared the treatment group to those who were already vitamin D replete, we found no significant difference in terms of recurrence rates or dizziness severity scores. This suggests that while Vitamin D3 treatment can reduce episodes of BPPV, its benefits may not extend to all older adults, particularly if they already have adequate vitamin D levels.
Overall, our findings lay the groundwork for further research into Vitamin D3's role in treating BPPV, potentially informing future clinical practice to help reduce risks of falls in older adults.
Our study involved participants who were initially vitamin D3 deficient. They were divided into two groups: one receiving a treatment of Vitamin D3 and the other a placebo. Over 12 months, participants who received the vitamin showed an impressive 87% reduction in their BPPV recurrence rates compared to those on placebo. Additionally, they experienced a longer time before their first episode of dizziness returned.
However, when we compared the treatment group to those who were already vitamin D replete, we found no significant difference in terms of recurrence rates or dizziness severity scores. This suggests that while Vitamin D3 treatment can reduce episodes of BPPV, its benefits may not extend to all older adults, particularly if they already have adequate vitamin D levels.
Overall, our findings lay the groundwork for further research into Vitamin D3's role in treating BPPV, potentially informing future clinical practice to help reduce risks of falls in older adults.
Read More
9
We investigated the impact of vitamin D supplementation on dizziness, specifically in individuals suffering from benign paroxysmal positional vertigo, commonly known as BPPV. Through a clinical study, we closely examined a group of patients diagnosed with BPPV, assessing their dizziness intensity using a simple scoring system.
Our findings highlighted that vitamin D deficient patients, who received weekly doses of vitamin D alongside rehabilitation, experienced a prolonged improvement in their vertigo symptoms compared to those who did not receive the vitamin. While both groups showed significant reduction in dizziness after two months, the benefits for those who had vitamin D supplementation remained stable even at six months’ follow-up, while the non-treated group saw a return of their symptoms to previous levels.
This suggests that correcting vitamin D deficiency not only plays a beneficial role in managing BPPV but also enhances the effectiveness of traditional rehabilitation methods, like the Epley maneuver, used in treating this condition. Overall, our observations point to the importance of checking vitamin D levels in patients who frequently experience BPPV for better treatment outcomes.
Our findings highlighted that vitamin D deficient patients, who received weekly doses of vitamin D alongside rehabilitation, experienced a prolonged improvement in their vertigo symptoms compared to those who did not receive the vitamin. While both groups showed significant reduction in dizziness after two months, the benefits for those who had vitamin D supplementation remained stable even at six months’ follow-up, while the non-treated group saw a return of their symptoms to previous levels.
This suggests that correcting vitamin D deficiency not only plays a beneficial role in managing BPPV but also enhances the effectiveness of traditional rehabilitation methods, like the Epley maneuver, used in treating this condition. Overall, our observations point to the importance of checking vitamin D levels in patients who frequently experience BPPV for better treatment outcomes.
Read More
9
We sought to understand the impact of severe vitamin D deficiency on benign paroxysmal positional vertigo (BPPV), a common cause of dizziness. Previous studies showed a connection between low vitamin D levels and both the onset and recurrence of BPPV, but none had conclusively demonstrated that addressing this deficiency could lessen the recurrence of symptoms.
To examine this further, we included patients diagnosed with unilateral, idiopathic posterior canal BPPV and severe vitamin D deficiency, indicated by levels of 25-hydroxyvitamin D3 at or below 10 ng/ml. After thorough evaluations including hearing tests and balance assessments, we prescribed vitamin D therapy to our participants.
Over the following months, we monitored the changes in their vitamin D levels and followed up with them for 18 months to observe any recurrence of dizziness. Our findings revealed that patients who showed an improvement in their vitamin D levels experienced a significant reduction in the recurrence of BPPV symptoms.
This suggests that by addressing vitamin D deficiency, we can potentially offer a more effective approach to managing BPPV—lessening those troublesome dizzy spells that can really impact quality of life.
To examine this further, we included patients diagnosed with unilateral, idiopathic posterior canal BPPV and severe vitamin D deficiency, indicated by levels of 25-hydroxyvitamin D3 at or below 10 ng/ml. After thorough evaluations including hearing tests and balance assessments, we prescribed vitamin D therapy to our participants.
Over the following months, we monitored the changes in their vitamin D levels and followed up with them for 18 months to observe any recurrence of dizziness. Our findings revealed that patients who showed an improvement in their vitamin D levels experienced a significant reduction in the recurrence of BPPV symptoms.
This suggests that by addressing vitamin D deficiency, we can potentially offer a more effective approach to managing BPPV—lessening those troublesome dizzy spells that can really impact quality of life.
Read More
User Reviews
USERS' SCORE
Moderately Good
Based on 3 Reviews
7.5
- All Reviews
- Positive Reviews
- Negative Reviews
9
Reduces dizziness
3 people found this helpful
I took this from the sixth month of pregnancy while breastfeeding. I observed my baby gained weight well and was healthy, which is different from my previous children. This is my experience, and I believe it helped with dizziness.
Read More
7.5
Eases dizziness
3 people found this helpful
I experienced increased dizziness and palpitations from four months pregnant. I began taking DHA as it’s beneficial for fetal brain development. Initially, there was a strong smell, but keeping it in the fridge helped. My dizziness has decreased, and I will continue taking it.
Read More
0
Helps with dizziness
11 people found this helpful
Good, but I am unsure about the Omega 3. I’ve experienced more severe dizziness with my anaemia during pregnancy. Initially, I didn’t realise how this was affecting me. I do take it now as I believe the fish oil can benefit my baby's intelligence.
Read More
Frequently Asked Questions
9
Reduces dizziness
3 people found this helpful
I took this from the sixth month of pregnancy while breastfeeding. I observed my baby gained weight well and was healthy, which is different from my previous children. This is my experience, and I believe it helped with dizziness.
7.5
Eases dizziness
3 people found this helpful
I experienced increased dizziness and palpitations from four months pregnant. I began taking DHA as it’s beneficial for fetal brain development. Initially, there was a strong smell, but keeping it in the fridge helped. My dizziness has decreased, and I will continue taking it.
0
Helps with dizziness
11 people found this helpful
Good, but I am unsure about the Omega 3. I’ve experienced more severe dizziness with my anaemia during pregnancy. Initially, I didn’t realise how this was affecting me. I do take it now as I believe the fish oil can benefit my baby's intelligence.
9
We conducted a double-blinded randomized controlled trial to explore the effects of Vitamin D3 on the recurrence of BPPV, a condition that causes dizziness in older adults.
Our study involved participants who were initially vitamin D3 deficient. They were divided into two groups: one receiving a treatment of Vitamin D3 and the other a placebo. Over 12 months, participants who received the vitamin showed an impressive 87% reduction in their BPPV recurrence rates compared to those on placebo. Additionally, they experienced a longer time before their first episode of dizziness returned.
However, when we compared the treatment group to those who were already vitamin D replete, we found no significant difference in terms of recurrence rates or dizziness severity scores. This suggests that while Vitamin D3 treatment can reduce episodes of BPPV, its benefits may not extend to all older adults, particularly if they already have adequate vitamin D levels.
Overall, our findings lay the groundwork for further research into Vitamin D3's role in treating BPPV, potentially informing future clinical practice to help reduce risks of falls in older adults.
Our study involved participants who were initially vitamin D3 deficient. They were divided into two groups: one receiving a treatment of Vitamin D3 and the other a placebo. Over 12 months, participants who received the vitamin showed an impressive 87% reduction in their BPPV recurrence rates compared to those on placebo. Additionally, they experienced a longer time before their first episode of dizziness returned.
However, when we compared the treatment group to those who were already vitamin D replete, we found no significant difference in terms of recurrence rates or dizziness severity scores. This suggests that while Vitamin D3 treatment can reduce episodes of BPPV, its benefits may not extend to all older adults, particularly if they already have adequate vitamin D levels.
Overall, our findings lay the groundwork for further research into Vitamin D3's role in treating BPPV, potentially informing future clinical practice to help reduce risks of falls in older adults.
9.5
We explored how vitamin D3, coupled with antioxidant supplements, can help prevent recurrent cases of benign paroxysmal positional vertigo (BPPV), a common type of dizziness. In this multicentric trial involving 128 patients who experienced frequent episodes of BPPV, we organized participants into three groups based on their vitamin D levels and treatment.
The first group received vitamin D3 along with a combination of alpha-lipoic acid, Carnosine, and Zinc, as well as vitamins from the B group. The second group, with sufficient vitamin D but no supplementation, served as a control. Meanwhile, the third group had sufficient vitamin D and received a different antioxidant mix.
After a six-month follow-up, we observed a significant reduction in dizziness relapses only among those in the first group who had insufficient or deficient vitamin D levels prior to treatment. Unfortunately, the other groups did not show similar improvements. This highlights the importance of addressing vitamin D deficiency, especially for those prone to recurrent dizziness. However, we must be cautious, as the combination of different supplements makes it challenging to isolate the effects solely attributed to vitamin D3.
The first group received vitamin D3 along with a combination of alpha-lipoic acid, Carnosine, and Zinc, as well as vitamins from the B group. The second group, with sufficient vitamin D but no supplementation, served as a control. Meanwhile, the third group had sufficient vitamin D and received a different antioxidant mix.
After a six-month follow-up, we observed a significant reduction in dizziness relapses only among those in the first group who had insufficient or deficient vitamin D levels prior to treatment. Unfortunately, the other groups did not show similar improvements. This highlights the importance of addressing vitamin D deficiency, especially for those prone to recurrent dizziness. However, we must be cautious, as the combination of different supplements makes it challenging to isolate the effects solely attributed to vitamin D3.
9.5
We explored how normalization of vitamin D levels may impact the recurrence of dizziness caused by benign paroxysmal positional vertigo (BPPV). This case-control study included patients with a history of BPPV who had low serum vitamin D levels. We divided participants into two groups: one received additional vitamin D3, while both groups underwent Epley rehabilitation therapy.
Over the course of two months, the treatment group raised their vitamin D levels significantly, while the control group did not see any change. Following this treatment period, we observed a remarkable difference in the recurrence of BPPV attacks; the group receiving vitamin D3 experienced far fewer episodes compared to the control group.
Our results indicate that boosting vitamin D3 levels significantly reduces the number of recurrent dizziness episodes in patients with BPPV. This suggests that addressing vitamin D deficiency may play a key role in managing dizziness in affected patients.
Over the course of two months, the treatment group raised their vitamin D levels significantly, while the control group did not see any change. Following this treatment period, we observed a remarkable difference in the recurrence of BPPV attacks; the group receiving vitamin D3 experienced far fewer episodes compared to the control group.
Our results indicate that boosting vitamin D3 levels significantly reduces the number of recurrent dizziness episodes in patients with BPPV. This suggests that addressing vitamin D deficiency may play a key role in managing dizziness in affected patients.
9
We sought to understand the impact of severe vitamin D deficiency on benign paroxysmal positional vertigo (BPPV), a common cause of dizziness. Previous studies showed a connection between low vitamin D levels and both the onset and recurrence of BPPV, but none had conclusively demonstrated that addressing this deficiency could lessen the recurrence of symptoms.
To examine this further, we included patients diagnosed with unilateral, idiopathic posterior canal BPPV and severe vitamin D deficiency, indicated by levels of 25-hydroxyvitamin D3 at or below 10 ng/ml. After thorough evaluations including hearing tests and balance assessments, we prescribed vitamin D therapy to our participants.
Over the following months, we monitored the changes in their vitamin D levels and followed up with them for 18 months to observe any recurrence of dizziness. Our findings revealed that patients who showed an improvement in their vitamin D levels experienced a significant reduction in the recurrence of BPPV symptoms.
This suggests that by addressing vitamin D deficiency, we can potentially offer a more effective approach to managing BPPV—lessening those troublesome dizzy spells that can really impact quality of life.
To examine this further, we included patients diagnosed with unilateral, idiopathic posterior canal BPPV and severe vitamin D deficiency, indicated by levels of 25-hydroxyvitamin D3 at or below 10 ng/ml. After thorough evaluations including hearing tests and balance assessments, we prescribed vitamin D therapy to our participants.
Over the following months, we monitored the changes in their vitamin D levels and followed up with them for 18 months to observe any recurrence of dizziness. Our findings revealed that patients who showed an improvement in their vitamin D levels experienced a significant reduction in the recurrence of BPPV symptoms.
This suggests that by addressing vitamin D deficiency, we can potentially offer a more effective approach to managing BPPV—lessening those troublesome dizzy spells that can really impact quality of life.
8
We conducted a study to understand how 1α-hydroxyvitamin D3 affects patients with benign paroxysmal positional vertigo (BPPV), a common cause of dizziness. In this study, we selected 100 BPPV patients from the ENT Department of Anzhen Hospital—50 received daily doses of 0.25 µg 1α-hydroxyvitamin D3 in addition to standard care, while the other 50 only received the usual treatment.
After analyzing the bone mineral density (BMD) and vitamin D levels before and after treatment, we discovered some promising results. The BMD of both male and female patients taking vitamin D3 significantly improved following treatment, which was not the case for the control group. Furthermore, we found that higher levels of vitamin D3 and the presence of osteopenia or osteoporosis played a crucial role in the effectiveness of BPPV treatment.
Our findings indicate that 1α-hydroxyvitamin D3 can effectively alleviate dizziness symptoms related to BPPV, making it a noteworthy addition to standard treatment protocols. This study highlights the importance of vitamin D levels in managing BPPV and suggests further exploration into its benefits for those suffering from dizziness.
After analyzing the bone mineral density (BMD) and vitamin D levels before and after treatment, we discovered some promising results. The BMD of both male and female patients taking vitamin D3 significantly improved following treatment, which was not the case for the control group. Furthermore, we found that higher levels of vitamin D3 and the presence of osteopenia or osteoporosis played a crucial role in the effectiveness of BPPV treatment.
Our findings indicate that 1α-hydroxyvitamin D3 can effectively alleviate dizziness symptoms related to BPPV, making it a noteworthy addition to standard treatment protocols. This study highlights the importance of vitamin D levels in managing BPPV and suggests further exploration into its benefits for those suffering from dizziness.
References
- Chua KW, Huang X, Koh XH, Soh JFJY, Barrera VC, et al. Randomized Controlled Trial Assessing Vitamin D's Role in Reducing BPPV Recurrence in Older Adults. Otolaryngol Head Neck Surg. 2025;172:127. doi:10.1002/ohn.954
- Libonati GA, Leone A, Martellucci S, Gallo A, Albera R, et al. Prevention of Recurrent Benign Paroxysmal Positional Vertigo: The Role of Combined Supplementation with Vitamin D and Antioxidants. Audiol Res. 2022;12:445. doi:10.3390/audiolres12040045
- Gu X, Dong F, Gu J. Analysis of effect of 1α-hydroxyvitamin D3 on benign paroxysmal positional vertigo and risk factors. Exp Ther Med. 2018;15:2321. doi:10.3892/etm.2018.5699
- Sheikhzadeh M, Lotfi Y, Mousavi A, Heidari B, Bakhshi E. The effect of serum vitamin D normalization in preventing recurrences of benign paroxysmal positional vertigo: A case-control study. Caspian J Intern Med. 2016;7:173.
- Sheikhzadeh M, Lotfi Y, Mousavi A, Heidari B, Monadi M, et al. Influence of supplemental vitamin D on intensity of benign paroxysmal positional vertigo: A longitudinal clinical study. Caspian J Intern Med. 2016;7:93.
- Talaat HS, Kabel AM, Khaliel LH, Abuhadied G, El-Naga HA, et al. Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency. Auris Nasus Larynx. 2016;43:237. doi:10.1016/j.anl.2015.08.009
- Mori K, Niimura S, Mizuno K. [A case of idiopathic hypoparathyroidism complicated with chronic thyroiditis]. Nihon Naibunpi Gakkai Zasshi. 1991;67:1339.
